Bio Green Med Solution, Inc.
BGMS
$0.86
-$0.02-2.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 710.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 710.00% | -- |
| Cost of Revenue | -- | -- | -37.04% | -93.22% | -- |
| Gross Profit | -- | -- | 114.12% | 101.82% | -- |
| SG&A Expenses | -60.21% | -90.77% | 31.86% | -18.84% | -23.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.63% | -75.70% | -4.38% | -50.94% | -65.76% |
| Operating Income | 66.53% | 94.16% | 40.81% | 54.43% | 65.72% |
| Income Before Tax | 68.27% | 96.03% | 67.38% | 54.41% | 65.99% |
| Income Tax Expenses | 350.00% | -- | -99.58% | -- | 100.49% |
| Earnings from Continuing Operations | 67.60% | 95.32% | 79.98% | 49.51% | 61.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 69.27% | -143.21% | 79.98% | 49.51% | 59.53% |
| EBIT | 66.53% | 94.16% | 40.81% | 54.43% | 65.72% |
| EBITDA | 66.52% | 94.18% | 41.00% | 54.41% | 65.72% |
| EPS Basic | 92.28% | 82.06% | 97.21% | 97.01% | 99.43% |
| Normalized Basic EPS | 92.29% | 99.73% | 99.73% | 98.93% | -- |
| EPS Diluted | 92.28% | 82.06% | 97.21% | 97.01% | 99.43% |
| Normalized Diluted EPS | 92.29% | 99.73% | 99.73% | 98.93% | -- |
| Average Basic Shares Outstanding | 311.49% | 1,394.69% | 11,865.71% | 4,178.52% | -- |
| Average Diluted Shares Outstanding | 311.49% | 1,394.69% | 11,865.71% | 4,178.52% | 7,098.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.67% | -- | -- | -- | -- |